Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DISC1 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DISC1 mRNA | decreases expression | 20064835
|
C055494 |
caffeic acid phenethyl ester |
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of DISC1 mRNA] | decreases reaction|increases expression | 20360939
|
D003024 |
Clozapine |
DISC1 gene mutant form results in decreased susceptibility to Clozapine | decreases response to substance | 20531374
|
D003024 |
Clozapine |
DISC1 protein affects the susceptibility to Clozapine | affects response to substance | 20531374
|
D004052 |
Diethylnitrosamine |
caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of DISC1 mRNA] | decreases reaction|increases expression | 20360939
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of DISC1 mRNA | increases expression | 20360939
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.25 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.25 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.44 | 19061943 19052882 17620307 17162532 16434500 18056438 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.54 | 14617031 16160616 12649775 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D020817 |
Asperger Syndrome |
marker/mechanism |
|
| 17579608 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17579608 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.05 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.87 | 20514400 16698587 10737359 17428255 17162532 20524982 20512989 17173139 16328049 19335982 16878318 21159647 20101231 19171122 18056438 16807293 18665156 20007298 18691550 19418558 19107877 20935162 18788625 19822196 20432363 19394651 16502159 18971187 18494052 16779866 19383236 11831363 16681979 17138121 18393292 3581430 19052882 20084675 17055752 18978308 18210153 19539802 19919837 16540662 20214788 16288022 18506893 17978847 19208518 18785209 17761372 19519916 10672840 16830150 3084413 19701751 16935385 16569478 20727157 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.09 | 21159647 2727394 17174075 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
4.01 | 19052882 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.45 | 17123785 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.93 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.93 | 20387270 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
6.17 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
2.13 | 19107877 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.43 | 16402076 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.73 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.56 | 21071580 20387270 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.82 | 20471113 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.45 | 16046005 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.53 | 18785209 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.93 | 10783313 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.73 | 15369732 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.21 | 16766008 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.21 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.99 | 18665156 19638242 20032147 18407596 18522880 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.89 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.89 | 20452335 20405173 18977376 2422723 18754104 10737359 21278145 20492335 19499222 19996281 18644402 19073162 19294768 20583210 19426721 9163691 15175105 19833225 19254457 19642983 19638242 12112319 20101389 19255062 19812893 19090486 18648771 21167192 20501860 21071580 20118626 12771043 19551842 20137499 20434301 19256749 19850985 16942905 15885732 2862719 18978307 19427195 19690152 21047994 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.83 | 19009564 18093689 16267830 18308698 19004024 16842330 17174075 19126423 2563599 18282651 21159647 17942915 17854601 18253720 19539802 3124819 18079962 18164116 18775883 19519916 18544905 9362446 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.46 | 20135361 18520028 6695378 18569708 17053015 20464547 20869020 18816296 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.46 | 20970405 6695378 20512841 21163286 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
4.48 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.72 | 19142101 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.68 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.31 | 11141357 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.65 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.73 | 20387270 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.08 | 18515891 19142110 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.52 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.88 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.43 | 15331141 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 20531374 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.77 | 20580759 20521320 18855531 20168265 20107430 17667964 20521326 17123785 17726453 19369910 20452607 11151749 11763009 18806925 16141801 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.51 | 10029692 19755658 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.40 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.25 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.29 | 17053015 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.79 | 20564506 16141801 16402076 20521320 17502770 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.62 | 17933447 |